Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
e1002195
Last reviewed: July 16, 2026 Last updated: July 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
It is important to note that at baseline, prior to initiation of Gla-300, the average length of tirzepatide treatment was 103.097.0 days (depending on the analysis set)
Rougemont M, Do KQ, Castagn V
US$ 21.67
US$ 27.73
US$ 21.89
US$ 22.55
US$ 26.73
US$ 23.94
US$ 23.35
